机构风向标 | 康缘药业(600557)2025年三季度已披露前十大机构持股比例合计下跌2.98个百分点

Group 1 - Kanyuan Pharmaceutical (600557.SH) reported its Q3 2025 results, with 14 institutional investors holding a total of 258 million shares, representing 45.62% of the company's total equity as of October 30, 2025 [1] - The top ten institutional investors collectively hold 45.53% of the shares, with a decrease of 2.98 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, five funds increased their holdings, accounting for a 0.66% increase compared to the previous period [2] - Three new public funds disclosed their holdings this quarter, while 151 funds did not disclose their holdings again, including major ETFs and bond funds [2]